The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers (original) (raw)
References
Pinkel, D. et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat. Genet.20, 207–211 (1998). ArticleCAS Google Scholar
Goldenring, J.R., Shen, K.R., Vaughan, H.D. & Modlin, I.M. Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung. J. Biol. Chem.268, 18419–18422 (1993). CAS Google Scholar
Wang, X., Kumar, R., Navarre, J., Casanova, J.E. & Goldenring, J.R. Regulation of vesicle trafficking in Madin-Darby canine kidney cells by Rab11a and Rab25 . J. Biol. Chem.275, 29138–29146 (2000). ArticleCAS Google Scholar
Shayesteh, L. et al. PI3KCA is implicated as an oncogene in ovarian cancer. Nat. Genet.21, 99–102 (1999). ArticleCAS Google Scholar
Fukushi, Y., Sato, S., Yokoyama, Y., Kudo, K., Maruyama, H., & Saito, Y. Detection of numerical aberrations in chromosome 17 and c-erbB2 gene amplification in epithelial ovarian cancer using recently established dual color FISH. Eur. J. Gynecol. Oncol.22, 23–25 (2001). CAS Google Scholar
Berchuck, A. & Carney, M. Human ovarian cancer of the surface epithelium. Biochem. Pharmacol.54, 541–544 (1997). ArticleCAS Google Scholar
Anand, N. et al. Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat. Genet.31, 301–305 (2002). ArticleCAS Google Scholar
Cheng, J.Q. et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA89, 9267–9271 (1992). ArticleCAS Google Scholar
Anzick, S.L. et al. AIB1, a steroid receptor co-activator amplified in breast and ovarian cancer. Science277, 965–967 (1997). ArticleCAS Google Scholar
Suzuki, S. et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res.60, 5382–5385 (2000). CAS Google Scholar
Patael-Karasik, Y. et al. Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel. Cancer Genet. Cytogenet.121, 26–32 (2000). ArticleCAS Google Scholar
Kiechle, M., Jacobsen, A., Schwarz-Boeger, U., Hedderich, J., Pfisterer, J. & Arnold, N. Comparative genomic hybridization detects genetic inbalance in primary ovarian carcinomas as correlated with grade of differentiation. Cancer91, 534–540 (2001). ArticleCAS Google Scholar
Zudaire, I. et al. Genomic imbalances detected by comparative genomic hybridization are prognostic markers in invasive ductal breast carcinomas. Histopathology40, 547–555 (2002). ArticleCAS Google Scholar
Lu, Y.J., Hing, S., Williams, R., Pinkerton, R., Shipley, J. & Pritchard-Jones, K. UK Children's Cancer Study Group Wilms' tumor group. Chromosome 1q expression profiling and relapse in Wilms' tumour. Lancet9330, 385–386 (2002). Article Google Scholar
Lu, K.H. et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin. Cancer Res.10, 3291–3300 (2004). ArticleCAS Google Scholar
Schaner, M.E. et al. Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell.14, 4376–4386 (2003). ArticleCAS Google Scholar
Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA100, 8418–8423 (2003). ArticleCAS Google Scholar
Calvo, A. et al. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res.62, 5325–5335 (2002). CAS Google Scholar
Mor, O. et al. Molecular analysis of transitional cell carcinoma using cDNA microarray. Oncogene22, 7702–7710 (2003). ArticleCAS Google Scholar
Wang, W. et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res.62, 6278–6288 (2002). CAS Google Scholar
Liu, J. et al. A genetically defined model for human ovarian cancer. Cancer Res.64, 1655–1663 (2004) ArticleCAS Google Scholar
Milhavet, O., Gary, D.S. & Mattson, M.P. RNA interference in biology and medicine. Pharmacol. Rev.55, 629–648 (2003). Article Google Scholar
Gross, A., McDonnell, J.M. & Korsmeyer, S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev.13, 1899–1911 (1999). ArticleCAS Google Scholar
Wei, M. et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science292, 727–730 (2001). ArticleCAS Google Scholar
Degenhardt, K., Chen, G., Lindsten, T. & White, E. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell2, 193–203 (2002). ArticleCAS Google Scholar
Lu, Y. et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene18, 7034–7045 (1999). ArticleCAS Google Scholar
Mills, G.B. et al. Role of abnormalities of PTEN and the phosphatidylinositol 3′ kinase pathway in breast and ovarian tumorigenesis, prognosis and therapy. Semin. Oncol.28, S125–S141 (2001). Article Google Scholar
Kennedy, S.G. et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev.11, 701–713 (1997). ArticleCAS Google Scholar
Delcroix, J.D., Valletta, J.S., Wu, C., Hunt, S.J., Kowal, A.S. & Mobley, W.C. NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals. Neuron39, 69–84 (2003). ArticleCAS Google Scholar